Bromination of Pyrimidines
255
A review of the literature failed to uncover any prior use of
sodium nitrite and a bromide salt as a method for bromination.
As our experience with the C-5 position of pyrimidines sug-
gested an electrophilic process, we initially considered this to
be the pathway for bromination. However, it was hard to
rationalize the oxidation of the bromine anion to a bromine
cation. The formation of the active brominating agent will have
to be examined further.
However, in an effort to further define a possible pathway for
the observed reactions, compound 1 was treated with Br2 in
glacial acetic acid. Analysis of the reaction mixture by gas
chromatography–mass spectrometry (GC-MS) showed that
compound 2 was, indeed, formed and isolated in a yield of
85 %. Consequently, formation of Br2 from NaNO2 and KBr is a
viable possibility for the actual brominating agent. Further
investigation of this observation is warranted and will be
pursued.
reasonable retention times compared with starting material, and
predictable ion fragmentation. In addition, melting points of
isolated products were obtained and were consistent with the
reported values.
Typical Experimental Procedure for Bromination
The pyrimidine (,1 mmol) was dissolved in glacial acetic acid
(,5 mL), and solid NaNO2 (,2 mmol) and solid KBr
(,2 mmol) were added all at once. An immediate evolution of
brown fumes was observed and the mixture was stirred at room
temperature (rt) overnight. Progress of the reaction was fol-
lowed by GC-MS analysis. In those cases where the reaction was
incomplete, as observed by the presence of starting pyrimidine,
additional NaNO2 was added and gentle heating applied
(,508C) for up to 1 h until no starting material was observed by
GC-MS analysis. Workup consisted of evaporation of the acetic
acid (in a fume hood at atmospheric pressure) followed by
suspension of the residue in Et2O (,20 mL). This was passed
through a short bed of silica gel (60–100 mesh), and eluted with
Et2O until the effluent showed no UV absorption. Evaporation
of the Et2O led to pure product.
We conclude from these experiments that any pyrimidine
containing at least one activating group adjacent to C-5 will
provide a 5-bromopyrimidine. Thus, this process represents a
novel approach to C-5 bromination under quite mild conditions
and without the use of either specialized brominating agents,
e.g. NBS, or harsh and toxic reagents, e.g. Br2.
5-Bromo-2,6-dichloro-4-dimethylaminopyrimidine 6: mp
96–988C. dH 3.254 ((CH3)2). dC 41.617 (N–CH3), 99.470
(C5–Br), 156.423 (C6–N), 161.474 (C4–Cl), 163.351 (C2–Cl).
m/z (HRMS) 270.9090. Calc. 270.9098. See Supplementary
Material for complete NMR and MS.
Experimental
All chemicals used in these reactions were obtained commer-
cially. 1H and 13C NMR spectra for compound 6 were obtained
in [D3]chloroform on an Agilent (Varian) Mercury-300 or Inova
500 instrument and a high-resolution mass spectrum (HRMS)
for compound 8 (see Supplementary Material) was obtained on a
Waters GCT mass spectrometer, coupled to an Agilent 7890 GC
instrument (with appropriate software that factors in relevant
isotope ratios and masses). Reactions were followed using the
same instrument employing the following conditions: GC oven
temperature raised from 408C to 3008C in 6.5 min and held at
3008C for 3.5 min; column was an MS-5, 10-m, 0.1-mm inside
diameter (ID), 0.1-mm film thickness; flow rate of 1 mL minꢀ1
and an ionization energy of 70 eV for the mass spectrometer.
Because the known compounds (2, mp 76–778C;[2] 4, mp
97–988C;[3] and 8, mp 63–648C[4]) have been adequately
described in the literature and the chemistry involved here does
not materially change the structures of the starting pyrimidines,
GC-MS spectra were used to confirm the expected product
formation. This confirmation included purity of the product,
Supplementary Material
1H NMR, 13C NMR, and HRMS spectra of compound 6 are
available on the Journal’s website.
References
[1] (a) Seepp. 329–342inD. J. Brown, ThePyrimidines1994 (JohnWiley&
Sons: New York, NY).
(b)Seep. 348inD. J. Brown, The Pyrimidines1994(John Wiley & Sons:
New York, NY).
(c) See p. 349in D. J. Brown, The Pyrimidines 1994(JohnWiley & Sons:
New York, NY).
(d)Seep. 350inD. J. Brown, The Pyrimidines1994(John Wiley & Sons:
New York, NY).
[2] R. C. Elderfield, R. N. Prasad, J. Org. Chem. 1960, 25, 1583.
[4] G. E. Hilbert, E. F. Jansen, J. Am. Chem. Soc. 1934, 56, 134.